NASHVILLE, Tenn. – January 6, 2026 – Embold Health is completing a transformative year defined by measurable employer impact, expanded clinical intelligence and strategic market momentum. The company’s continued advancements in provider quality insights, responsible AI and partnerships helped employers and health plans improve health outcomes and lower costs while advancing a clearer, data-driven navigation experience.

“This was a defining year for Embold,” said Daniel Stein, MD, MBA, President and Founder of Embold. “We’ve spent years building the analytics, clinical rigor and trust needed to truly improve healthcare decision-making and this year we were able to scale our impact in a meaningful way. I’m incredibly proud of our team for remaining focused on Embold’s mission— helping employers and health plans manage costs while empowering people to choose high quality care.”

As employers and health plans face rising costs and increasing complexity, many are rethinking short-term cost controls in favor of decisions that meaningfully shape health outcomes. Embold’s approach reflects this shift, focusing on helping members make better care choices at the moment those decisions matter most, rather than relying on blunt utilization levers after the fact.

Across diverse employer populations, organizations that aligned benefit design with Embold’s provider quality insights achieved up to 5.46% reductions in per-member-per-year healthcare costs in recent analyses, demonstrating consistent results across more than 325,000 covered lives in five states. For example, an employer with 10,000 employees and an average annual spend of $10,000 per member could save $5.5 million in potential annual savings with this approach.  

Additionally, Embold strengthened its clinical intelligence portfolio by expanding our clinically validated, specialty-specific quality models in areas such as oncology, rheumatology, allergy and otolaryngology, enabling more precise provider performance differentiation. Product enhancements delivered clearer quality distinctions and more actionable decision support at key moments in the care journey.

As healthcare decisions become more complex, Embold continued to focus on making quality more personal, connecting people to the right provider for their specific needs, at the right time. AI plays a critical role in enabling that match at scale, when paired with clinically grounded data and clear navigation pathways.  

Building on its foundation of validated provider-quality data, Embold advanced its generative AI tools to deliver more clinically contextual guidance and support clearer, more informed healthcare decisions. Embold’s Virtual Assistant, EVA, is purposefully designed to solve one of healthcare’s toughest challenges: connecting people to high-quality care efficiently, effectively, and equitably through a natural language interface and integrated access. Responsible AI principles remained central to product development, ensuring accuracy and safety.

Embold achieved key trust and transparency milestones, including external validation of its methodology and recognition for predictive and preventive analytics from the Validation Institute and HITRUST’s r2 interim assessment.

In June 2025, Quantum Health completed the acquisition of Embold, aligning the two organizations’ complementary capabilities in pursuit of a shared commitment to improving the healthcare navigation experience at scale. The partnership brings together Embold’s clinically grounded analytics, quality insights and AI capabilities with Quantum’s established navigation platform, creating a stronger foundation for evidence-based, personalized guidance across millions of members.

“Our decision to join Quantum Health was rooted in the shared belief that scale matters when the goal is real impact,” said Stein. “Quantum gives us the opportunity to deploy Embold’s clinically grounded analytics and quality intelligence across millions of members, while continuing to do what we do best. Together, we have greater reach, deeper investment and the ability to bring evidence-based navigation to more people without compromising the rigor, accuracy or transparency that sets Embold apart.”

Embold enters 2026 with strong momentum and a continued commitment to improving outcomes through clinically backed, transparent and trusted intelligence. With a continued focus on expanding specialty insights and advancing responsible AI, Embold is poised to shape a more informed, accountable, and quality-driven future for healthcare.

About Embold Health

Embold Health helps employers and health plans guide members to higher-quality care, improving outcomes and reducing unnecessary healthcare spending. Through clinically grounded analytics and generative AI, Embold empowers members to make clearer, more confident care decisions across the full care journey. Evaluating 21 specialties and 68 sub-specialties, Embold’s patented and peer-reviewed provider quality score methodology analyzes data from 230+ million individuals across the entire care journey at the individual physician performance level.  

Embold delivers clinically grounded analytics, quality intelligence and generative AI that enables clearer navigation and more confident care choices. In 2025, Embold Health joined Quantum Health, the most complete healthcare navigation solution, expanding its ability to bring evidence-based, personalized provider guidance to millions of members at their first moment of need. To learn more, visit emboldhealth.com.

Media Contact
Name: Ellie Meyer
Email: ellie@jxtcollective.com